Month: January 2025

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

Staff January 2, 2025

IND submission for intranasal SPC-15 treatment expected in 2025; Phase 1 clinical trial to follow upon approvalSP-26 ketamine implants nearing...

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products

Staff January 2, 2025

PITTSBURGH, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health...

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

Staff January 2, 2025

DURHAM, N.C., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations...

Lexicon Appoints Scott Coiante as Chief Financial Officer

Staff January 2, 2025

THE WOODLANDS, Texas, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the appointment of Scott...

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

Staff January 2, 2025

FREMONT, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today...

GCAN to Explore Strategic Alternatives in Artificial Intelligence and Quantum Computing

Staff January 2, 2025

Company today announced a major strategic step forward as it explores new growth avenuesArtificial Intelligence (AI) and Quantum Computing industries...

SELLAS to Host Corporate Update Call on January 8, 2025, at 9:00 am ET

Staff January 2, 2025

NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a...

Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Staff January 2, 2025

SOUTH SAN FRANCISCO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that Bernard Coulie,...

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

Staff January 2, 2025

Vancouver, Canada, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...

TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

Staff January 2, 2025

Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox and cowpoxJapan Biotechno...

Atavistik Bio Announces Research Collaboration with Pfizer to Accelerate Discovery of Novel Precision Allosteric Therapeutics

Staff January 2, 2025

Collaboration will leverage Atavistik Bio’s proprietary AMPS™ platform to rapidly identify and validate novel allosteric binders against two undisclosed, Pfizer-designated...

Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development

Staff January 2, 2025

Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development (OXFORDSHIRE,...

Month: January 2025

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

Lexicon Appoints Scott Coiante as Chief Financial Officer

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

GCAN to Explore Strategic Alternatives in Artificial Intelligence and Quantum Computing

SELLAS to Host Corporate Update Call on January 8, 2025, at 9:00 am ET

Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

Atavistik Bio Announces Research Collaboration with Pfizer to Accelerate Discovery of Novel Precision Allosteric Therapeutics

Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development

Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer

Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare Conference

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025

Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder

BioStem Technologies CEO to Present at Biotech Showcase 2025

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

The Ensign Group Closes on Expansion in Tennessee, Adds Its First Operation in Alabama

Park Systems Corp. Acquires Lyncée Tec SA, Expanding Optical Metrology Portfolio

Baracoda Unveils BConnect: The World’s First AI-Powered Platform for Rapid IoT Development

Scryb Announces Non-Brokered Private Placement of Secured Convertible Debentures

ITRI Unveils Cutting-Edge Smart Medical Technology at CES 2025

SHOWCASING TOMORROW’S INNOVATORS: LG NOVA RETURNS TO CES 2025

You may have missed